OptimizeRx OPRX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.4M+4.6% | —— | —— | —— | $3.25M— | ||
| $4.73M-5.1% | —— | —— | —— | $4.99M— | ||
| $1.83M+17.3% | —— | —— | —— | $1.56M-48.5% | ||
| $1.06M-2.7% | $1.08M-1.5% | $1.08M-1.4% | $1.07M+0.1% | $1.09M+2.5% | ||
| $19.45M-19.1% | —— | —— | —— | $24.03M— | ||
| -$495K+77.5% | $5.02M+6,536% | $779K+109% | $1.53M+138% | -$2.2M+68.1% | ||
| —— | $92K-95.1% | $92K-95.1% | $92K-95.1% | $92K-95.1% | ||
| $358K+106% | $325K+12.8% | $174K-4.4% | $437K+139% | $174K-4.4% | ||
| —— | —— | —— | —— | —— | ||
| $12K— | $753K+368% | $0+100% | $1.09M+1,121% | $0-100% | ||
| $1.43M+16.7% | -$401K+33.1% | —— | -$1.4M-206% | $1.23M+318% | ||
| -$5.76M-4.9% | —— | -$1.29M-171% | —— | -$5.49M+13.8% | ||
| -$7.99M-1,035% | $1.46M-52.1% | —— | $3.28M+273% | $854K+336% | ||
| $166K+337% | $108K+43.5% | -$89K-218% | —— | $38K-49.5% | ||
| -$2K— | —— | $6K— | $9K— | $0— | ||
| $290K+492% | $19K+101% | —— | $1.03M-54.3% | -$74K+90.8% | ||
| $798K-28.8% | $916K-56.8% | $980K-28.5% | $1.17M-14.2% | $1.12M-17.0% | ||
| -$2.71M-361% | -$3.45M-22.1% | -$258K+51.5% | -$4.51M-392% | -$587K+8.3% | ||
| -$21K+75.0% | $206K+272% | -$10K+89.1% | -$44K+48.2% | -$84K+45.1% | ||
| -$467K-112% | $7.09M+3,480% | $3.2M+78.8% | $4.56M+483% | $3.86M+82.4% | ||
| $17K-80.5% | —— | —— | $5K-98.8% | $87K-37.9% | ||
| $21K-22.2% | $11K-35.3% | $10K-44.4% | $10K-77.8% | $27K-15.6% | ||
| $0-100% | —— | —— | $34K-15.0% | $57K-52.9% | ||
| $0— | $0-100% | $0+100% | $0— | $0-100% | ||
| $2.69M+438% | $2.5M0.0% | $500K0.0% | $4.5M+800% | $500K0.0% | ||
| $1.83M+17.3% | $1.96M-33.3% | $1.96M-24.9% | $1.49M-48.7% | $1.56M-48.5% | ||
| $1.46M+245% | $9.65M— | $3.13M+142% | $4.26M+259% | -$1.01M+74.6% | ||
| $396K+119% | $8.57M— | $2.05M+124% | $3.19M+185% | -$2.1M+58.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is OptimizeRx's revenue?
- OptimizeRx (OPRX) generated $107.3M in revenue over the trailing twelve months, up 39.8% year over year.
- Is OptimizeRx profitable?
- OptimizeRx reported $6.8M in net income over the trailing twelve months, a 6.4% net margin.
- What are OptimizeRx's profit margins?
- Gross margin is 70.0% and operating margin is 13.2%, with a 6.4% net margin.
- What is OptimizeRx's earnings per share?
- OptimizeRx's diluted EPS over the trailing twelve months is $0.35.
- Where does OptimizeRx's income statement data come from?
- Every line is extracted from OptimizeRx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
